References
- Murube J. Antecedents of Sjogren syndrome. Ocul Surf. 2010;8(2):49–59. doi:https://doi.org/10.1016/S1542-0124(12)70068-X.
- Murube J. The first definition of Sjögren’s syndrome. Ocul Surf. 2010;8(3):101–110. doi:https://doi.org/10.1016/S1542-0124(12)70221-5.
- Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s syndrome international registry. Am J Ophthalmol. 2010;149(3):405–415. doi:https://doi.org/10.1016/j.ajo.2009.09.013.
- Sjogren H. Some problems concerning keratoconjunctivitis sicca and the siccasyndrome. Acta Ophthalmol (Copenh). 2009;29(1):33–48. doi:https://doi.org/10.1111/j.1755-3768.1951.tb07613.x.
- Maldini C, Seror R, Fain O, et al. Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area: primary SS epidemiology in France. Arthritis Care Res. 2014;66(3):454–463. doi:https://doi.org/10.1002/acr.22115.
- Fernández-Ávila DG, Rincón-Riaño DN, Bernal-Macías S, Gutiérrez Dávila JM, Rosselli D. Prevalence and demographic characteristics of Sjögren’s syndrome in Colombia, based on information from the Official Ministry of Health Registry. Reumatol Clínica Engl Ed. 2020;16(4):286–289. doi:https://doi.org/10.1016/j.reumae.2018.09.016.
- Bron AJ, De Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510. doi:https://doi.org/10.1016/j.jtos.2017.05.011.
- Liew M, Shiao H, Zhang M, Kim E, Akpek EK. Prevalence and predictors of Sjögren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96(12):1498–1503. doi:https://doi.org/10.1136/bjophthalmol-2012-301767.
- Akpek EK, Klimava A, Thorne JE, Martin D, Lekhanont K, Ostrovsky A. Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea. 2009;28(5):493–497. doi:https://doi.org/10.1097/ICO.0b013e31818d3846.
- Saldanha IJ, Bunya VY, McCoy SS, Makara M, Baer AN, Akpek EK. Ocular manifestations and burden related to Sjögren’s syndrome: results of a patient survey. Am J Ophthalmol. 2020;219:40–48. doi:https://doi.org/10.1016/j.ajo.2020.05.043.
- The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf. 2007;5(2):75–92. doi:https://doi.org/10.1016/S1542-0124(12)70081-2.
- Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19(3):201–211. doi:https://doi.org/10.1076/ceyr.19.3.201.5309.
- Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology. 1998;105(8):1485–1488. doi:https://doi.org/10.1016/S0161-6420(98)98033-2.
- Akpek EK, Mathews P, Hahn S, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmology. 2015;122(1):56–61. doi:https://doi.org/10.1016/j.ophtha.2014.07.026.
- Akpek EK, Bunya VY, Saldanha IJ. Sjögren’s syndrome: more than just dry eye. Cornea. 2019;38(5):658–661. doi:https://doi.org/10.1097/ICO.0000000000001865.
- Bunya VY, Bhosai SJ, Heidenreich AM, et al. Association of dry eye tests with extraocular signs among 3514 participants in the Sjögren’s syndrome international registry. Am J Ophthalmol. 2016;172:87–93. doi:https://doi.org/10.1016/j.ajo.2016.09.013.
- Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren’s syndrome. Medicine (Baltimore). 1965;44(3):187–231. doi:https://doi.org/10.1097/00005792-196505000-00001.
- Eisenberg RA. Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract. J Immunol. 1985;135: 1707 LP - 1713.
- Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G. Genetics and epigenetics in primary Sjögren’s syndrome. Rheumatology. Published online. 2019 February 15. doi:https://doi.org/10.1093/rheumatology/key330.
- Harley J, Reichlin M, Arnett F, Alexander E, Bias W, Provost T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren’s syndrome. Science. 1986;232(4754):1145–1147. doi:https://doi.org/10.1126/science.3458307.
- Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya J-M. HLA and Sjögren’s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev. 2012;11(4):281–287. doi:https://doi.org/10.1016/j.autrev.2011.10.002.
- Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet. 2013;45(11):1284–1292. doi:https://doi.org/10.1038/ng.2792.
- Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjögren’s syndrome. Genes Immun. 2009;10(4):285–296. doi:https://doi.org/10.1038/gene.2009.20.
- Shen L, He J, Kramer JM, Bunya VY. Sjögren’s syndrome: animal models, etiology, pathogenesis, clinical subtypes, and diagnosis. J Immunol Res. 2019;2019:1–3. doi:https://doi.org/10.1155/2019/8101503.
- Savitsky D, Tamura T, Yanai H, Taniguchi T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother CII. 2010;59(4):489–510. doi:https://doi.org/10.1007/s00262-009-0804-6.
- Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005;434(7030):243–249. doi:https://doi.org/10.1038/nature03308.
- Adrianto I, Wen F, Templeton A, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet. 2011;43(3):253–258. doi:https://doi.org/10.1038/ng.766.
- Nocturne G, Tarn J, Boudaoud S, et al. Germline variation of TNFAIP3 in primary Sjögren’s syndrome-associated lymphoma. Ann Rheum Dis. 2016;75(4): 780LP - 783. doi:https://doi.org/10.1136/annrheumdis-2015-207731.
- Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72(2):162–165. doi:https://doi.org/10.1006/clin.1994.1123.
- Tapinos NI, Polihronis M, Tzioufas AG, Moutsopoulos HM. Sjögren’s Syndrome. In: Mallia C, Uitto J, eds. Rheumaderm. Vol 455. Advances in Experimental Medicine and Biology. Springer US; 1999:127–134. doi:https://doi.org/10.1007/978-1-4615-4857-7_18.
- Lee SY, Han SJ, Nam SM, et al. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and Non–Sjögren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247–253.e1. doi:https://doi.org/10.1016/j.ajo.2013.04.003.
- Delaleu N, Nguyen CQ, Peck AB, Jonsson R. Sjögren’s syndrome: studying the disease in mice. Arthritis Res Ther. 2011;13(3):217. doi:https://doi.org/10.1186/ar3313.
- Anaya J-M, Gómez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin Dev Immunol. 2006;13(2–4):185–195. doi:https://doi.org/10.1080/17402520600876762.
- Sharma R, Harris VM, Cavett J, et al. Brief report: rare X chromosome abnormalities in systemic lupus erythematosus and Sjögren’s syndrome. Arthritis Rheumatol. 2017;69(11):2187–2192. doi:https://doi.org/10.1002/art.40207.
- Harris VM, Sharma R, Cavett J, et al. Klinefelter’s syndrome (47,XXY) is in excess among men with Sjögren’s syndrome. Clin Immunol. 2016;168:25–29. doi:https://doi.org/10.1016/j.clim.2016.04.002.
- Liu K, Kurien BT, Zimmerman SL, et al. X chromosome dose and sex bias in autoimmune diseases: increased 47,XXX in systemic lupus erythematosus and Sjögren’s syndrome. Arthritis Rheumatol. Published online December 2015. doi:https://doi.org/10.1002/art.39560.
- Pflugfelder SC. Tear dysfunction and the cornea: LXVIII Edward Jackson memorial lecture. Am J Ophthalmol. 2011;152(6):900–909.e1. doi:https://doi.org/10.1016/j.ajo.2011.08.023.
- Mircheff AK. Sjogrens syndrome as failed local immunohomeostasis: prospects for cell-based therapy. Ocul Surf. 2003;1(4):160–179. doi:https://doi.org/10.1016/S1542-0124(12)70012-5.
- Vivino FB, Bunya VY, Massaro-Giordano G, et al. Sjogren’s syndrome: an update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81–121. doi:https://doi.org/10.1016/j.clim.2019.04.009.
- Lee OL, Tepelus TC, Huang J, et al. Evaluation of the corneal epithelium in non-Sjögren’s and Sjögren’s dry eyes: an in vivo confocal microscopy study using HRT III RCM. BMC Ophthalmol. 2018;18(1):309. doi:https://doi.org/10.1186/s12886-018-0971-3.
- Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11(4):246–258. doi:https://doi.org/10.1016/j.jtos.2013.07.003.
- Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100(3):300–306. doi:https://doi.org/10.1136/bjophthalmol-2015-307415.
- Pflugfelder SC, De Paiva CS, Li D-Q, Stern ME. Epithelial-immune cell interaction in dry eye. Cornea. 2008;27(Suppl 1):S9–S11. doi:https://doi.org/10.1097/ICO.0b013e31817f4075.
- Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol Chic IL 1960. 2012;130(1):90–100. doi:https://doi.org/10.1001/archophthalmol.2011.364.
- Rosenthal P, Borsook D. Ocular neuropathic pain. Br J Ophthalmol. 2016;100(1):128–134. doi:https://doi.org/10.1136/bjophthalmol-2014-306280.
- Tuisku IS, Konttinen YT, Konttinen LM, Tervo TM. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren’s syndrome. Exp Eye Res. 2008;86(6):879–885. doi:https://doi.org/10.1016/j.exer.2008.03.002.
- Le Goff M, Cornec D, Jousse-Joulin S, et al. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome. Arthritis Res Ther. 2017;19(1):269. doi:https://doi.org/10.1186/s13075-017-1475-x.
- Beckman KA, Luchs J, Milner MS, Ambrus JL. The potential role for early biomarker testing as part of a modern, multidisciplinary approach to Sjögren’s syndrome diagnosis. Adv Ther. 2017;34(4):799–812. doi:https://doi.org/10.1007/s12325-017-0501-3.
- Bunya VY, Massaro-Giordano M, Vivino FB, et al. Prevalence of novel candidate Sjögren syndrome autoantibodies in the Penn Sjögren’s international collaborative clinical alliance cohort. Cornea. 2019;38(12):1500–1505. doi:https://doi.org/10.1097/ICO.0000000000002147.
- Shen L, Malyavantham K, Suresh L, et al. Early detection of Sjögren’s syndrome; sensitivity and specificity of the Sjö® diagnostic test. Invest Ophthalmol Vis Sci. 2016;57(12): 5681–5681. doi:https://doi.org/10.1167/iovs-16-20648.
- Karakus S, Baer AN, Agrawal D, Gurakar M, Massof RW, Akpek EK. Utility of novel autoantibodies in the diagnosis of Sjögren’s syndrome among patients with dry eye. Cornea. 2018;37(4):405–411. doi:https://doi.org/10.1097/ICO.0000000000001471.
- De Langhe E, Bossuyt X, Shen L, Malyavantham K, Ambrus JL, Suresh L. Evaluation of autoantibodies in patients with primary and secondary Sjogren’s syndrome. Open Rheumatol J. 2017;11(1):10–15. doi:https://doi.org/10.2174/1874312901711010010.
- Montes-Mico R, Alio JL, Charman WN. Dynamic changes in the tear film in dry eyes. Investig Opthalmol Vis Sci. 2005;46(5):1615. doi:https://doi.org/10.1167/iovs.05-0017.
- Ridder WH, Tomlinson A, Huang J-F, Li J. Impaired visual performance in patients with dry eye. Ocul Surf. 2011;9(1):42–55. doi:https://doi.org/10.1016/S1542-0124(11)70009-X.
- Vivino FB, Minerva P, Huang CH, Orlin SE. Corneal melt as the initial presentation of primary Sjögren’s syndrome. J Rheumatol. 2001;28:379.
- Pfister RR, Murphy GE. Corneal ulceration and perforation associated with Sjogren’s syndrome. Arch Ophthalmol. 1980;98(1):89–94. doi:https://doi.org/10.1001/archopht.1980.01020030091006.
- Shan SJC, Wu EI, Akpek EK. Sterile corneal melt after descemet stripping endothelial keratoplasty in patients with previously undiagnosed Sjögren syndrome. Arch Ophthalmol. 2009;127(2):219–221. doi:https://doi.org/10.1001/archophthalmol.2008.601.
- Murtagh P, Comer R, Fahy G. Corneal perforation in undiagnosed Sjögren’s syndrome following topical NSAID and steroid drops post routine cataract extraction. BMJ Case Rep. 2018;bcr-2018-225428. doi:https://doi.org/10.1136/bcr-2018-225428.
- Rosenbaum JT, Bennett RM. Chronic anterior and posterior uveitis and primary Sjögren’s syndrome. Am J Ophthalmol. 1987;104(4):346–352. doi:https://doi.org/10.1016/0002-9394(87)90223-6.
- Sun J-Y, Liu Z, Zhao P, Liu T. Optic neuritis as an initial presentation of primary Sjögren syndrome. Medicine (Baltimore). 2016;95(44):e5194. doi:https://doi.org/10.1097/MD.0000000000005194.
- Gmuca S, Lieberman SM, Mehta J. Pediatric neuromyelitis optica spectrum disorder and Sjögren syndrome: more common than previously thought? J Rheumatol. 2017;44(6):959–960. doi:https://doi.org/10.3899/jrheum.160978.
- Shiboski CH, Baer AN, Shiboski SC, et al. Natural history and predictors of progression to Sjögren’s syndrome among participants of the Sjögren’s international collaborative clinical alliance registry. Arthritis Care Res. 2018;70(2):284–294. doi:https://doi.org/10.1002/acr.23264.